Mirum Pharmaceuticals Inc. has announced the granting of inducement awards to four new employees as part of its 2020 Inducement Plan. On September 10, 2025, the Compensation Committee of the company's Board of Directors approved non-qualified stock options for the purchase of 10,820 shares of common stock and 5,390 restricted stock units (RSUs). The stock options are set at an exercise price of $74.89 per share, aligned with the closing trading price on the grant date. These options will vest over a four-year period, with 25% vesting after one year and the remaining shares vesting monthly over the subsequent 36 months. The RSUs will vest over three years, with 33% of the shares vesting annually. These awards are contingent upon the new employees maintaining their service relationship with Mirum Pharmaceuticals.